Testosterone therapy and prostate cancer
The use of exogenous testosterone to treat hypogonadism in the men with a history of prostate cancer (CaP) remains controversial due to fears of cancer recurrence or progression. Due to the detrimental impact of hypogonadism on patient quality of life, recent work has examined the safety of testoste...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
AME Publishing Company
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182214/ |